Riskpilot← Back to searchSign inGet full accessJolinda AB
ABActiveOrg 5565754057Tallåsvägen 28Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19990 employees
Revenue 2024
SEK 79K
-23% vs 2023
EBITDA margin
50.3%
-45% vs 2023
Equity ratio
78.9%
Financial strength
Net profit 2024
SEK 77K
+53% vs 2023
| Revenue | SEK 79K | -23% |
| EBITDA | SEK 40K | -45% |
| Net profit | SEK 77K | +53% |
| Total assets | SEK 513K | +6% |
| Equity | SEK 405K | +24% |
| Employees | 0 | — |
Legal name
Jolinda AB
Org number
5565754057
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
10 september 1999
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva försäljning av drogtestprodukter, konsultationer och föreläsningar inom samhällsfrågor, droger och drogtester, samt idka annan därmed förenlig verksamhet.
Address
Tallåsvägen 28
Email
petter.birath@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 56 | 71 | 25 | 103 | 79 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 33 | 50 | 4 | 72 | 40 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 33 | 50 | 4 | 72 | 40 |
| Net financials | −1 | −1 | −0 | −0 | 3 |
| Profit before tax | 36 | 50 | 17 | 64 | 99 |
| Tax | −8 | −11 | −4 | −14 | −21 |
| Net profit | 28 | 39 | 13 | 51 | 77 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 397 | 406 | 406 | 485 | 513 |
| Equity | 265 | 264 | 277 | 327 | 405 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 38 | 48 | 48 | 68 | 75 |
| Total debt | 38 | 48 | 48 | 68 | 75 |
EBITDA margin
50.3%
This company
15.8%
Market median
+218% vs market
20202024
Equity ratio
78.9%
This company
38.2%
Market median
+107% vs market
20202024
Return on equity
19.1%
This company
18.4%
Market median
+4% vs market
20202024
Net profit margin
97.6%
This company
8.1%
Market median
+1105% vs market
20202024
Asset turnover
0.15×
This company
1.12×
Market median
-87% vs market
20202024
Debt / equity
0.27×
This company
0.62×
Market median
+56% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2025 | |
| Board of Directors | 2025 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2025 | |
| Former (1) | ||
| Board of Directors | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Jolinda AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Erik Keijser | Chairman | 0 companies |
| Max Johan Birath | Board of Directors | 0 companies |
| Inger Elisabeth Birath | Deputy Board Member | 0 companies |
| Johan Petter Birath | Board of Directors | 0 companies |
| Johan Börje Birath | Board of Directors | 0 companies |